Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

[Uptodate in the management and treatment of ANCA-associated vasculitis].

Belaconi IN, Toma CL, Bogdan MA.

Pneumologia. 2014 Apr-Jun;63(2):78-80, 83-6. Review. Romanian.

PMID:
25241554
2.

HLA-DR in Brazilian patients with polyarteritis nodosa (PAN) and microscopic polyangiitis (MPA).

de Lira Freire A, Conde RA, Bertolo MB, Costallat LT, Levy-Neto M, Fernandes SR.

Dis Markers. 2009;26(3):105-9. doi: 10.3233/DMA-2009-0616.

3.

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, Bombardieri S, Choi H, Combe B, Dougados M, Emery P, Gomez-Reino J, Keystone E, Koch G, Kvien TK, Martin-Mola E, Matucci-Cerinic M, Michaud K, O'Dell J, Paulus H, Pincus T, Richards P, Simon L, Siegel J, Smolen JS, Sokka T, Strand V, Tugwell P, van der Heijde D, van Riel P, Vlad S, van Vollenhoven R, Ward M, Weinblatt M, Wells G, White B, Wolfe F, Zhang B, Zink A, Felson D; EULAR; ACR.

Arthritis Rheum. 2008 Oct 15;59(10):1371-7. doi: 10.1002/art.24123.

4.

EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints.

Bertsias GK, Ioannidis JP, Boletis J, Bombardieri S, Cervera R, Dostal C, Font J, Gilboe IM, Houssiau F, Huizinga T, Isenberg D, Kallenberg CG, Khamashta M, Piette JC, Schneider M, Smolen J, Sturfelt G, Tincani A, van Vollenhoven R, Boumpas DT, Gordon C.

Ann Rheum Dis. 2009 Apr;68(4):477-83. doi: 10.1136/ard.2007.083030. Epub 2008 Apr 23. Review.

PMID:
18434449
5.

EULAR points to consider for conducting clinical trials in systemic lupus erythematosus.

Gordon C, Bertsias G, Ioannidis JP, Boletis J, Bombardieri S, Cervera R, Dostál C, Font J, Gilboe IM, Houssiau F, Huizinga TW, Isenberg D, Kallenberg CG, Khamashta MA, Piette JC, Schneider M, Smolen JS, Sturfelt G, Tincani A, Van Vollenhoven R, Boumpas DT.

Ann Rheum Dis. 2009 Apr;68(4):470-6. doi: 10.1136/ard.2007.083022. Epub 2008 Apr 3. Review.

PMID:
18388158
6.

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.

Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, Gross WL, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott D, Witter J, Yazici H, Luqmani RA; European Vasculitis Study Group (EUVAS).

Ann Rheum Dis. 2008 Jul;67(7):1004-10. Epub 2007 Oct 2. Review.

7.

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.

Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott DG, Witter J, Yazici H, Luqmani RA.

Ann Rheum Dis. 2007 May;66(5):605-17. Epub 2006 Dec 14. Review.

Supplemental Content

Loading ...
Support Center